Cover image of the article: Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination

Image Credit:Jundishapur J Microbiol

Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination

Authors

Ahmad Shamsizadeh1,*, Manoochehr Makvandi2, Gholamali Shoshtari2
1Jundishapur Infectious and Tropical Diseases Research Centre, and Abuzar Childrens Hospital, Ahvaz Jundishapur University of Medical Sciences, Shamsizadeh@ajums.ac.ir, Iran
2Jundishapur Infectious and Tropical Diseases Research Centre, Ahvaz Jundishapur University of Medical Sciences, Iran
*Corresponding Author: Jundishapur Infectious and Tropical Diseases Research Centre, and Abuzar Childrens Hospital, Ahvaz Jundishapur University of Medical Sciences, Shamsizadeh@ajums.ac.ir, Iran. Tel: +98611 2215365. Fax: +98611 444711. Email: Shamsizadeh@ajums.ac.ir

Jundishapur Journal of Microbiology:Vol. 4, issue 1
Published online:Jan 31, 2011
Article type:Research Article
How to Cite:Shamsizadeh A, Makvandi M, Shoshtari G. Prevalence of anti hepatitis B surface antibody among children in Ahvaz, Iran, five years after vaccination. Jundishapur J Microbiol. 2011;4(1):. doi:

Abstract

Introduction and objective: The public vaccination program of hepatitis B virus was started in 1993 in Iran, and all children received three doses of hepatitis B vaccine in 0, 2 and 6 months of age routinely. The objective of this study was to determine the prevalence of antibody to hepatitis B surface (anti-HBs) five years after vaccination.

Materials and methods: In a cross-sectional study, anti-HBs was determined in six year old girl and boy students of selected elementary schools of Ahvaz with enzyme-linked immunosorbent assay (ELISA) method in 2006. All children had received complete course of hepatitis B vaccination in the first year of age.

Results: Four hundred and twenty seven students (223 girls and 204 boys) were enrolled in the study. Of them, 75.4% were anti-HBs positive (>10 mIU/mL). The prevalence of anti-HBs was statistically different between males and females (P=0.02).

Conclusion: The study detected anti-HBs in 75.4% of children and because of possibility of presence of anamnestic responses in seronegative subjects, a booster dose of vaccine is not necessary at least five years after primary vaccination. Further studies are needed to evaluate hepatitis B immunity in older age groups.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2011, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

12
Jan
2014
Serum Levels of Anti-Hepatitis B Surface Antibody Among Vaccinated Population Aged 1 to 18 Years in Ahvaz City Southwest of Iran

Serum Levels of Anti-Hepatitis B Surface Antibody Among Vaccinated Population Aged 1 to 18 Years in Ahvaz City Southwest of Iran

Reza Norouzirad,
Abdol Hussein Shakurnia,
Mohammad-Ali Assarehzadegan,
Amirarsalan Serajian,
Mehdi Khabazkhoob

Norouzirad R, Shakurnia AH, Assarehzadegan M, Serajian A, Khabazkhoob M. Serum Levels of Anti-Hepatitis B Surface Antibody Among Vaccinated Population Aged 1 to 18 Years in Ahvaz City Southwest of Iran. Hepat Mon. 2014;14(1):e13625. doi: https://doi.org/10.5812/hepatmon.13625

30
Jun
2009
Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Hamid Galehdari,
Majid Yavarian,
Bita Geramizadeh,
oranous bashti shiraz

Galehdari H, Yavarian M, Geramizadeh B, bashti shiraz O. Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran. Hepat Mon. 2011;11(9):. doi: https://doi.org/10.5812/kowsar.1735143X.732

30
Jun
2009
Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Farahnaz Fallahian,
Seyed Moayed Alavian

Fallahian F, Alavian SM. Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran. Hepat Mon. 2008;8(1):. doi:

30
Jun
2009
Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Mona Isa,
Mortada El-Shabrawi

Isa M, El-Shabrawi M. Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran. Hepat Mon. 2011;11(5):. doi:

30
Jun
2009
Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran

Fatemeh Derakhshan,
Hamid Hourfar,
Roya Derakhshan,
Fariborz Rajab,
Maziar Mojtabavi Naini

Derakhshan F, Hourfar H, Derakhshan R, Rajab F, Mojtabavi Naini M. Evaluation of the Level of HBV Antibody Titer after HBV Vaccination among Children in Tehran, Iran. Hepat Mon. 2007;7(2):. doi:

More by these authors

Ahmad ShamsizadehPubMedScholar
Manoochehr MakvandiPubMedScholar
Gholamali ShoshtariPubMedScholar
Share
Cited by
Metrics